Consolidated Edison Reports Q1 Earnings, Reaffirms 2026 Guidance, Settles $776M Equity Issuance
ED is trading near its 52-week low of $94.96 (12% above the low).
Summary
Consolidated Edison announced Q1 2026 earnings, reaffirmed its full-year guidance, completed a $357.5 million asset sale, and settled a $776 million equity issuance to fund capital investments.
Key Events · Earnings and Guidance · ED
-
Q1 2026 Earnings
Reported GAAP EPS of $2.55 (up from $2.26 in Q1 2025) and adjusted EPS of $2.18 (down from $2.26 in Q1 2025).
-
2026 Guidance Reaffirmed
Maintained full-year adjusted EPS guidance in the range of $6.00 to $6.20 per share, indicating a stable outlook.
-
$776 Million Equity Issuance
Completed the physical settlement of a February 2026 forward sale agreement, issuing 7 million common shares to fund ongoing capital investments.
-
$357.5 Million Asset Sale
Completed the sale of its equity interest in Mountain Valley Pipeline, LLC, generating a GAAP gain and supporting strategic portfolio management.
Analysis · ED · Energy & Transportation
Consolidated Edison reported mixed first-quarter 2026 results, with GAAP EPS increasing to $2.55 while adjusted EPS slightly decreased to $2.18. The company reaffirmed its full-year 2026 adjusted EPS guidance, signaling a stable outlook. Financially, the company completed the physical settlement of a February 2026 forward sale agreement, issuing 7 million common shares for $776 million. While dilutive, these proceeds are crucial for funding the company's multi-year capital investment plan, as outlined in its recent 10-K. Additionally, Consolidated Edison completed the strategic sale of its interest in Mountain Valley Pipeline, LLC for $357.5 million, generating a GAAP gain and further streamlining its asset portfolio.
At the time of this filing, ED was trading at $106.39 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $39.2B. The 52-week trading range was $94.96 to $116.23. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.